liver cancer
Tencent Invests $30M in Early Cancer Detection Firm Insighta
Hong Kong-based Prenetics, which had a 50 percent stake in Insighta, sold some of its secondary shares and will now hold a 35 percent stake in the company.
Quest's Haystack Oncology, U of Montreal to Study Liquid Biopsy MRD Test in Colorectal Cancer
The partners will use Haystack's MRD test to assess treatment response and detect early relapse in colorectal cancer patients with liver metastasis.
The company recently published data on the MESA platform's ability to screen for colorectal cancer and is considering other testing opportunities.
Chinese Liver Cancer Atlas Reveals Potential Drivers, Mutational Histories
Researchers analyzed genome sequences for 494 hepatocellular carcinoma cases from China, identifying alteration patterns distinct from those described in other populations.
Liver, Gallbladder Cancer Pharmacogenomics Investigated with Organoid Multiomics
Researchers profiled multiomic features and drug sensitivity patterns in dozens of patient-derived tumor organoids established with samples from Chinese hepatobiliary cancer patients.